Global Epidermolysis Bullosa Therapeutics Market Outlook, 2019-2023; Dominated by Amryt Pharma, Fresenius, Johnson & Johnson, Novartis, and Pfizer - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 7, 2019--The "Global Epidermolysis Bullosa Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
